The Food and Drug Administration (FDA) is classifying the scalp cooling system to reduce the likelihood of chemotherapy-induced alopecia into class II (special controls). The special controls that will apply to the device are identified in this order and will be part of the codified language for the scalp cooling system to reduce the likelihood of chemotherapy-induced alopecia's classification. The Agency is classifying the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device.
Document
Medical Devices; General and Plastic Surgery Devices; Classification of the Scalp Cooling System To Reduce the Likelihood of Chemotherapy-Induced Alopecia
The Food and Drug Administration (FDA) is classifying the scalp cooling system to reduce the likelihood of chemotherapy-induced alopecia into class II (special controls). The sp...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
81 FR 7452
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Medical Devices; General and Plastic Surgery Devices; Classification of the Scalp Cooling System To Reduce the Likelihood of Chemotherapy-Induced Alopecia,” thefederalregister.org (February 12, 2016), https://thefederalregister.org/documents/2016-02878/medical-devices-general-and-plastic-surgery-devices-classification-of-the-scalp-cooling-system-to-reduce-the-likelihood-.